Skip to content

Effects of AMP Application After Non-surgical Periodontal Therapy on Treatment of Periodontitis

Effects of Antimicrobial Peptides Application After Non-surgical Periodontal Therapy on Treatment of Stage III and Grade B Periodontitis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05530252
Enrollment
51
Registered
2022-09-07
Start date
2022-09-05
Completion date
2023-01-30
Last updated
2024-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Periodontitis

Brief summary

Chronic periodontitis is an infectious disease of periodontal support tissues caused by bacterial biofilm, which leads to inflammation and destruction of periodontal support tissues ultimately resulting in tooth loss.In the clinic, patients with Stage III and Grade B periodontitis are difficult to gain desired outcomes on account of deep periodontal pockets, complicated anatomy, the removal of subgingival dental biofilms, and control of residual inflammation. A large number of studies have indicated that the effectiveness of local application of antibiotics as an adjunct to scaling and root planning (SRP), such as the antimicrobial and minocycline hydrochloride could affect bacterial metabolism and inhibit biofilm attachment particularly in terms of pocket depth reduction and attachment level gain. However, the use of wide-spectrum antibiotics may cause some inevitable side effects including drug resistance, pathogens and probiotics were eliminated leading to diversity of microbiota diminished, and toothstaining. To solve the problems of antibiotics in the clinic, antimicrobial peptides (AMPs) may be considered as an alternative to conventional antibiotics drugs.In this randomized clinical trial, we aimed to evaluate the effects of AMPs as an addition to SRP on clinical parameters and microbiological biofilms in patients with Stage III and Grade B periodontitis.

Interventions

DRUGOral biological antimicrobial gel

The patients were divided into subgingival scaling, and Oral Biological Antimicrobial Gel was used in the periodontal pocket after scaling. The injection probe with gel was inserted into the periodontal pocket, and the injection was slowly pushed, and the injection was gradually withdrawn during the injection, until a little gel was found at the mouth of the bag.

DRUGminocycline hydrochloride ointment

The patients were divided into subgingival scaling, and minocycline hydrochloride ointment was used in the periodontal pocket after scaling. The injection probe with gel was inserted into the periodontal pocket, and the injection was slowly pushed, and the injection was gradually withdrawn during the injection, until a little gel was found at the mouth of the bag.

OTHERSRP

only scaling and root planning was performed on the patient

Sponsors

Beijing Stomatological Hospital, Capital Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

The patients did not know their group or the drugs they were given

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years old * Previously untreated Stage III and Grade B periodontitis by clinically and radiologically。In 2018, EEP and AAP sorted out periodontitis into four classifications (Stage I to IV) based on several variables including clinical attachment loss, amount and percentage of bone loss, probing depth, presence and extent of angular bony defects and furcation involvement, tooth mobility, and tooth loss due to periodontitis, and three levels (grade A: low risk, grade B: moderate risk, grade C: high risk of progression) according to the rate of disease progression. * A minimum of 20 natural teeth in the mouth, and more than 4 molars.

Exclusion criteria

* Acute oral lesions or necrotizing ulcerative periodontitis, * Having received antibiotics within 6 months or the need for antibiotic coverage during experiment, * Being allergic to minocycline, * No orthodontic treatment, * A history of systemic diseases, * Pregnancy, * Smoker

Design outcomes

Primary

MeasureTime frameDescription
Periodontal Probing DepthChange from Baseline Periodontal probing depth at 90 daysfrom the gingival margin to the bottom of the periodontal pocket were assessed using a Williams periodontal probe((Hu-Friedy)
Attachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)Change from Baseline Attachment level at 90 daysfrom the cementoenamel junction, crown margin or restoration to the bottom of the pocket
Bleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.Change from Bleeding index at 90 daysBleeding index : 0 = normal appearance of the gingiva and no bleeding on sulcus probing. 1. = normal appearance of the gingiva but bleeding on probing of the sulcus. 2. = bleeding on probing and gingival color change without swelling. 3. = bleeding on probing, gingival color change with mild swelling. 4. = bleeding on probing with marked gingival swelling, with or without color change. 5. = bleeding on probing, L Spontaneous bleeding, gingival color change with marked swelling, with or without ulceration.

Countries

China

Participant flow

Participants by arm

ArmCount
AMP Group
scaling and root planning and subgingival application of antimicrobial peptide gel Oral biological antimicrobial gel: The patients were divided into subgingival scaling, and Oral Biological Antimicrobial Gel was used in the periodontal pocket after scaling. The injection probe with gel was inserted into the periodontal pocket, and the injection was slowly pushed, and the injection was gradually withdrawn during the injection, until a little gel was found at the mouth of the bag.
17
Perio Group
scaling and root planning and subgingival application of minocycline hydrochloride ointment minocycline hydrochloride ointment: The patients were divided into subgingival scaling, and minocycline hydrochloride ointment was used in the periodontal pocket after scaling. The injection probe with gel was inserted into the periodontal pocket, and the injection was slowly pushed, and the injection was gradually withdrawn during the injection, until a little gel was found at the mouth of the bag.
17
SRP Group
scaling and root planning SRP: only scaling and root planning was performed on the patient
17
Total51

Withdrawals & dropouts

PeriodReasonFG000FG001FG002
Overall StudyLost to Follow-up111

Baseline characteristics

CharacteristicAMP GroupPerio GroupSRP GroupTotal
Age, Continuous38.73 years
STANDARD_DEVIATION 14.03
37.93 years
STANDARD_DEVIATION 12.74
38.50 years
STANDARD_DEVIATION 10.01
38.39 years
STANDARD_DEVIATION 10.54
Probing depth5.0 millimeter4.9 millimeter5.0 millimeter5.0 millimeter
Race and Ethnicity Not Collected0 Participants
Sex: Female, Male
Female
11 Participants10 Participants10 Participants31 Participants
Sex: Female, Male
Male
6 Participants7 Participants7 Participants20 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 170 / 170 / 17
other
Total, other adverse events
0 / 170 / 170 / 17
serious
Total, serious adverse events
0 / 170 / 170 / 17

Outcome results

Primary

Attachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)

from the cementoenamel junction, crown margin or restoration to the bottom of the pocket

Time frame: Change from Baseline Attachment level at 90 days

Population: Three subjects did not return to the clinic as required and were not included in the final data analysis of the study

ArmMeasureValue (MEAN)
AMP GroupAttachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)1.0 millimeter
Perio GroupAttachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)1.7 millimeter
SRP GroupAttachment Level Were Assessed Using a Williams Periodontal Probe((Hu-Friedy)2.0 millimeter
Primary

Bleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.

Bleeding index : 0 = normal appearance of the gingiva and no bleeding on sulcus probing. 1. = normal appearance of the gingiva but bleeding on probing of the sulcus. 2. = bleeding on probing and gingival color change without swelling. 3. = bleeding on probing, gingival color change with mild swelling. 4. = bleeding on probing with marked gingival swelling, with or without color change. 5. = bleeding on probing, L Spontaneous bleeding, gingival color change with marked swelling, with or without ulceration.

Time frame: Change from Bleeding index at 90 days

Population: Three subjects did not return to the clinic as required and were not included in the final data analysis of the study

ArmMeasureValue (MEAN)
AMP GroupBleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.0.7 score on a scale
Perio GroupBleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.1.1 score on a scale
SRP GroupBleeding Index Were Assessed Using a Williams Periodontal Probe((Hu-Friedy) ,the Rating Method Was Assessed Using the Criteria of Mazza.1.3 score on a scale
Primary

Periodontal Probing Depth

from the gingival margin to the bottom of the periodontal pocket were assessed using a Williams periodontal probe((Hu-Friedy)

Time frame: Change from Baseline Periodontal probing depth at 90 days

Population: Three subjects did not return to the clinic as required and were not included in the final data analysis of the study

ArmMeasureValue (MEAN)
AMP GroupPeriodontal Probing Depth2.5 millimeter
Perio GroupPeriodontal Probing Depth3.2 millimeter
SRP GroupPeriodontal Probing Depth3.4 millimeter

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026